» Articles » PMID: 19161771

Redo Valvular Surgery in Elderly Patients

Overview
Journal Ann Thorac Surg
Publisher Elsevier
Date 2009 Jan 24
PMID 19161771
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Elderly patients older than the age of 75 constitute 13% of the population that undergoes cardiac surgery at our institution and represent the fastest growing population in Ontario. We have witnessed an increasing proportion of elderly patients being referred for repeat surgical intervention for valvular heart disease. We determined the perioperative and long-term outcomes in elderly patients undergoing redo cardiac valve surgery.

Methods: A retrospective review of our institutional database identified 112 patients aged 75 years or older (mean age, 78 +/- 3 years; range, 75 to 89 years) who underwent redo valve surgery between 1990 and 2004. All patients presented with a previous surgical intervention on the valve of interest. The mean follow-up was 5 +/- 4 years and was 100% complete.

Results: Eighty-eight patients (79%) had isolated valve surgery at their primary operation whereas 24 patients (21%) had concomitant coronary artery bypass grafting at the time of their initial valve surgery. At reoperation, 74 patients (66%) underwent single valve surgery (40 aortic valve, 34 mitral valve), 33 patients (29.5%) required double valve surgery, and 5 patients (4.5%) had triple valve surgery. Thirty-three patients (29.5%) required concomitant coronary artery bypass grafting, among whom 14 patients had a previous coronary artery bypass graft surgery. There were 12 operative (10.7%) and 47 late deaths (42%). Cardiovascular events were the cause of death in 32 patients (54% of all deaths). Overall survival at 5 years was 67% +/- 5%. The freedom from valve-related mortality and morbidity was 86% +/- 4% at 5 years. Mean intensive care eunit stay was 3.7 +/- 4.5 days, and postoperative hospital stay was 15 +/- 12 days.

Conclusions: Redo valvular surgery in an elderly cohort can be performed with acceptable morbidity and mortality. Although 5-year survival is lower than that observed with a younger patient population, it is still likely higher than expected survival without surgical intervention. Despite increased resource utilization, elderly patients should be offered redo surgical intervention for valvular heart disease.

Citing Articles

Effects of Bioprosthetic Valve Fracturing on Valve-in-Valve Transcatheter Aortic Valve Implantation Transvalvular Gradients.

Hallak O, Fischer K, Ailawadi S, Valencia D, Yatsynovich Y, Nazir R Tex Heart Inst J. 2024; 51(2):e238304.

PMID: 39582677 PMC: 11584884. DOI: 10.14503/THIJ-23-8304.


Redo-TAVR for bioprosthetic valve degeneration with obvious neoplasm in a left cerebral infarction patient.

Liu W, Li D, Qu Z, Tang G, Liu S, Li Y Clin Case Rep. 2024; 12(8):e9315.

PMID: 39119032 PMC: 11305981. DOI: 10.1002/ccr3.9315.


Transcatheter Aortic Valve Replacement in Special Populations.

Ahmad K, Mentias A, Imran H, Elbadawi A, Hyder O, Gordon P Rev Cardiovasc Med. 2024; 24(2):49.

PMID: 39077422 PMC: 11273143. DOI: 10.31083/j.rcm2402049.


VARC-3 defined outcome of valve-in-valve transcatheter aortic valve implantation in stentless compared with stented aortic bioprostheses.

Steul J, Abdel-Wahab M, Stankowski T, Haussig S, Woitek F, Gasior T Clin Res Cardiol. 2023; .

PMID: 38078955 DOI: 10.1007/s00392-023-02347-5.


Does ozaki procedure have a future as a new surgical approach for aortic valve replacement? a systematic review and meta-analysis.

Awad A, Farahat R, Reda Gad E, Abdelgalil M, Hassaballa A Ann Med Surg (Lond). 2023; 85(9):4454-4462.

PMID: 37663695 PMC: 10473333. DOI: 10.1097/MS9.0000000000000982.